EMEDOG, 1 MG/ML, SOLUTION FOR INJECTION FOR DOGS
EMEDOG, 1 MG/ML, SOLUTION FOR INJECTION FOR DOGS
Authorised
- Apomorphine hydrochloride hemihydrate
Product identification
Medicine name:
EMEDOG, 1 MG/ML, SOLUTION FOR INJECTION FOR DOGS
EMEDOG 1 mg/ml SOLUCIÓN INYECTABLE PARA PERROS
Active substance:
- Apomorphine hydrochloride hemihydrate
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Apomorphine hydrochloride hemihydrate1.17milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN04BC07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Livron
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 3283 ESP
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0281/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
Germany
-
Greece
-
Ireland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 2/08/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/03/2023
How useful was this page?: